Fatty Liver Disease and Overweight

NOW RECRUITING

-

Adelaide SA

A study to investigate the effect of a new medication in adults with Fatty Liver Disease and Obesity who are at risk of developing worsening liver disease.

Do you have a diagnosis of fatty liver disease?
Do you have diabetes, high blood pressure or high cholesterol?
Are you over 50 years old?

If you answered "yes" to these questions above, you are more likely to fulfil the eligibility criteria.

Age > 18 years
BMI ≥ 25kg/m2
Previous liver scan preferable
Weekly self-injection
Elevated Liver Fat content - assessed at screening
Not taking Ozempic/Mounjaro
No history of surgical treatment for obesity (some exceptions)
Not diabetic type 1

Outpatient Visit

Screening visit (part 1 and part 2)
Monthly clinic visits for 6 months
Then clinic visits every 2 months

Payment / Remuneration

Reimbursed for travel $75 per visit
Reimbursment for meals at fasting visits up to $48 (with receipt)

Information for Practitioners

Screening bloods
Liver fat content ≥8% (on MRI)
VCTE-LSM ≥10<20kPa (on Fibroscan) - assessed at screening visit
Fundus photography for diabetic participants
No history of liver cirrhosis
Exclusion - alcohol intake >21 units/week (males) or >14 units/week (females)
No history of cancers >5 years prior to screening (some exceptions)